| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 105,562 | 100,551 | 86,221 | | Cost of Revenue | 46,937 | 45,507 | 39,362 | | | Gross Profit | 58,625 | 55,044 | 46,859 | | | Operating Expenses | | Research Development | 8,361 | 6,966 | 6,180 | | Selling General and Administrative | 32,469 | 30,370 | 26,304 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 17,795 | 17,708 | 14,375 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,271 | 2,096 | 1,774 | | Earnings Before Interest And Taxes | 19,066 | 19,804 | 16,149 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 19,066 | 19,804 | 16,149 | | Income Tax Expense | 7,053 | 7,301 | 6,076 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,013 | 12,503 | 10,073 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 12,013 | 12,503 | 10,073 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,013 | $12,503 | $10,073 |
|
1.48% Nasdaq 
Income Statement
